Beam Therapeutics, Inc. (BEAM)
31.45
-0.89
(-2.75%)
USD |
NASDAQ |
May 07, 15:43
Beam Therapeutics SG&A Expense (TTM) : 113.82M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 119.80M |
| Twist Bioscience Corp. | 196.87M |
| Stryker Corp. | 8.632B |
| Zimmer Biomet Holdings, Inc. | 3.348B |
| Tandem Diabetes Care, Inc. | 444.99M |